SFRP2 and neoplasm: Functional analyses in human breast [37], gastric [23,24] and colorectal cancer cell lines [19] revealed a pro-apoptotic and anti-proliferative capacity of (human) SFRP2 associated with the ability to inhibit activated Wnt signaling, altogether supporting a tumor suppressive rather than an oncogenic function of this gene.